OMERS Administration Corp’s Juno Therapeutics, Inc. JUNO Stock Holding History

OMERS Administration Corp’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-102,700	Closed	-$3.08M	–	622
2016 Q3	$3.08M	Buy	102,700 +54,200	+112%	+$1.69M	0.05%	193
2016 Q2	$1.86M	Buy	+48,500	New	+$2.01M	0.04%	243
2015 Q4	–	Sell	-6,800	Closed	-$277K	–	562
2015 Q3	$277K	Buy	+6,800	New	+$298K	0.01%	367

Other funds holding JUNO

Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BCM

Biomark Capital Management Greenwich, Connecticut $8.9M AUM 97.06% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

OMERS Administration Corp's JUNO Position: Q4 2016 in Review

OMERS Administration Corp sold out of Juno Therapeutics, Inc. (JUNO) in Q4 2016, closing a stake of 102,700 shares — an estimated $3.08M sold.

OMERS Administration Corp first reported a position in JUNO in Q3 2015 and held it in 3 quarters. The position peaked at $3.08M in Q3 2016. 159 funds tracked by Wall St. Rank hold JUNO as of Q4 2016.

OMERS Administration Corp reported no remaining Juno Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
OMERS Administration Corp sold 102,700 Juno Therapeutics, Inc. shares in Q4 2016, an estimated $3.08M.
OMERS Administration Corp first reported a position in Juno Therapeutics, Inc. in Q3 2015 and held it in 3 quarters.
OMERS Administration Corp's Juno Therapeutics, Inc. position peaked at $3.08M in Q3 2016.
159 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q4 2016.

Based on OMERS Administration Corp's 13F filing for Q4 2016, filed 9 Feb 2017.